Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.

dc.contributor.author	Bernabeu Morón, Ignacio
dc.date.accessioned	2017-06-07T07:22:35Z
dc.date.available	2017-06-07T07:22:35Z
dc.date.issued	2011
dc.identifier.issn	0804-4643
dc.identifier.uri	http://hdl.handle.net/20.500.11940/5714
dc.language.iso	eng
dc.title	Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.
dc.type	Artigo	es
dc.authorsophos	van der Lely, Aart-Jan
dc.authorsophos	Bernabeu, Ignacio
dc.authorsophos	Cap, Jan
dc.authorsophos	Caron, Philippe
dc.authorsophos	Colao, Annamaria
dc.authorsophos	Marek, Josef
dc.authorsophos	Neggers, Sebastian
dc.authorsophos	Birman, Pascal
dc.identifier.doi	10.1530/EJE-10-0867
dc.identifier.isi	287969100002
dc.identifier.pmid	21148630
dc.identifier.sophos	10153
dc.issue.number	3
dc.journal.title	EUROPEAN JOURNAL OF ENDOCRINOLOGY
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Endocrinoloxía
dc.page.initial	325
dc.page.final	33
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	164

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.